Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what assessment the Government has made of the potential effect of the UK withdrawing from Euratom on (a) the NHS budget and (b) the provision of NHS cancer treatments.

The United Kingdom’s ability to import medical isotopes from Europe and the rest of the world will not be affected by withdrawing from Euratom. Medical radio-isotopes, used in the treatment of some cancers, are not subject to Euratom Supply Agency contracts or to Euratom safeguards. The Government remains committed to improving outcomes for all cancer patients and has confirmed funding of over £600 million between 2017/18 and 2020/21 to deliver on the independent Cancer Taskforce’s Strategy for England and invested £142 million on cancer research in 2015/16.